BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, July 6, 2026
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for January 16, 2025

Jan. 16, 2025
New hires and promotions in the med-tech industry, including: Actineer, Biacure Therapies, Tactile Systems, Interim Diagnostic, Modular Devices, Pangia Biotech.
Read More

Appointments and advancements for Jan. 15, 2025

Jan. 15, 2025
New hires and promotions in the biopharma industry, including: Metagenomi, Neomorph, Nrx, Serina, Sunshine, Verastem.
Read More

Appointments and advancements for January 15, 2025

Jan. 15, 2025
New hires and promotions in the med-tech industry, including: Deepsight Technology, Freudenberg Medical, Glucotrack, Medidata.
Read More

Appointments and advancements for Jan. 14, 2025

Jan. 14, 2025
New hires and promotions in the biopharma industry, including: Calcimedica, Jeune Aesthetics, Ose.
Read More

Appointments and advancements for January 14, 2025

Jan. 14, 2025
New hires and promotions in the med-tech industry, including: Alcami, CMR Surgical, Endogenex, Kinomica, Medquest, Metabolon, Microaire, Solera.
Read More

Appointments and advancements for January 14, 2025

Jan. 14, 2025
New hires and promotions in biopharma in Asia-Pacific, including: Eccogene.
Read More

Appointments and advancements for Jan. 13, 2025

Jan. 13, 2025
New hires and promotions in the biopharma industry, including: Amphista, Avacta, Avanzanite, Context, Hemab, Outrun, Yaqrit.
Read More

Appointments and advancements for January 13, 2025

Jan. 13, 2025
New hires and promotions in the med-tech industry, including: Brain.Q, Establishment Lab Holdings, Microbot Medical, Scientia Vascular, Symbio, Tactile Systems, Vaso Corp.
Read More

Appointments and advancements for Jan. 10, 2025

Jan. 10, 2025
New hires and promotions in the biopharma industry, including: Achieve, Ariceum, Artbio, Belharra, Catalym, Chemify, Enveda, Spero, Terremoto, Totus, Tourmaline, Y-mabs.
Read More

Appointments and advancements for January 10, 2025

Jan. 10, 2025
New hires and promotions in the med-tech industry, including: Becton Dickinson, Cytosurge, Cytrellis Biosystems, Diagnamed, Edap, Genomics, LGC, Mendaera, Neogenomics, Philips, Pulse Biosciences.
Read More
Previous 1 2 … 61 62 63 64 65 66 67 68 69 … 327 328 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 6, 2026.
  • CINP 2026: Prenatal and adolescent stress shape brain vulnerability

    BioWorld Science
    Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
  • Ontrack Therapeutics divulges compounds for neurodegenerative diseases

    BioWorld Science
    Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
  • Modius Spero wearable neuromodulation device

    Neurovalens granted FDA approval for PTSD therapy for US veterans

    BioWorld
    Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
  • IPO puzzle pieces

    Neuracle eyes Shanghai IPO as global BCI funding surges

    BioWorld
    Neuracle Medical Technology Co. Ltd. is seeking a Shanghai IPO that could make it China’s first publicly listed invasive brain-computer interface (BCI) company,...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing